|
Costs (CAD)
|
|
Total program
|
$20,053,297
|
$18,759,518
|
$18,132,468
|
$20,059,786
|
$43,165,976
|
$41,743,817
|
|
Per woman screening
|
$201
|
$188
|
$181
|
$201
|
$432
|
$417
|
|
Per case of T21 diagnosed prenatally
|
$82,005
|
$76,529
|
$74,112
|
$81,169
|
$161,305
|
$159,510
|
|
Per case of T21 diagnosed prenatally (all cfDNA screening no-call have a PND)
|
$81,998
|
$76,691
|
$74,149
|
$81,455
|
$167,680
|
$162,167
|
|
Per additional case of T21 diagnosed compared to the contingent cfDNA screening
|
–
|
–
|
–
|
$3799
|
$1,795,639
|
$1,687,537
|
|
Number of patient visit and turnaround time
|
|
Number of visit (1st cfDNA screening has result)
|
3
|
1
|
1
|
1
|
1
|
1
|
|
Number of visit (1st cfDNA screening no-call result)
|
4
|
1
|
1
|
1
|
2
|
1
|
|
Days from initial sample received to cfDNA screening result (1st cfDNA screening has result)
|
16
|
13
|
7
|
7
|
10
|
4
|
|
Days from initial sample received to cfDNA screening result (1st cfDNA screening no-call result)
|
26
|
13
|
7
|
7
|
20
|
4
|
